As shown in Figure 4E,F, loss of TRIM10 drastically promoted the activation of NF-κB in AML cells (p < 0.01), whereas overexpression of TRIM10 suppressed the activation of NF-κB in AML cells (Figure 4H, p < 0.01). Here, TRIM10 is linked to acute myeloid leukemia.